Extrinsic allergic alveolitis: Inhibitory effects of pentoxifylline on cytokine production by alveolar macrophages

Annals of Allergy, Asthma and Immunology

Volumn 92, Issue 2, 2004, Pages 234-239

  Tong, Zhaohui ^a   Chen, Baomin ^a   Dai, Huaping ^a   Bauer, Peter C ^a   Guzman, Josune ^b   Costabel, Ulrich ^a,c  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c RUHRLANDKLINIK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DEXAMETHASONE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; PENTOXIFYLLINE; SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR 1; SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ALLERGIC PNEUMONITIS; ARTICLE; BLOOD RHEOLOGY; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRANULOMATOUS INFLAMMATION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOTHERAPY; INFLAMMATION; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MALE; PRIORITY JOURNAL; SUPERNATANT; T LYMPHOCYTE;

EID: 1242351754     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61553-0     Document Type: Article

References (43)

1. Ward A, Clissold SP. Pentoxifylline: a review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy. Drugs. 1987;34:40-97.
2. Han J, Thompson P, Beutler B. Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate point in the signaling pathway. J Exp Med. 1990;172:391-394.
3. Marques LJ, Zheng L, Poulakis N, Guzman J, Costabel U. Pentoxifylline inhibits TNFα production from human alveolar macrophages. Am J Respir Crit Care Med. 1999;159:508-511.
4. Neuner P, Klosner M, Schauer M, et al. Pentoxifylline in vivo down-regulates the release of IL-1, IL-6, IL-8, and tumor necrosis factor-α by human peripheral blood mononuclear cells. Immunology. 1994;83:262-267.
5. Poulakis N, Androutsos G, Kazi D, et al. The differential effect of pentoxifylline on cytokine production by alveolar macrophages and its clinical implication. Respir Med. 1999;93:52-57.
6. D'Hellencourt CL, Diaw L, Cornillet P, Guenounou M. Differential regulation of TNFα, IL-1β, IL-6, IL-8, TNFβ, and IL-10 by pentoxifylline. Int J Immunopharmacol. 1996;18:739-748.
7. Benbernou N, Esnault S, Potron G, Guenounou M. Regulatory effects of pentoxifylline on T-helper cell-derived cytokine production in human blood cells. J Cardiovasc Pharmacol. 1995; 25(Suppl):S75-S79.
8. Bienvenu J, Doche C, Gutowski MC, Lenoble M, Lepape A, Perdrix JP. Production of proinflammatory cytokines and cytokines involved in the TH1/TH2 balance is modulated by pentoxifylline. J Cardiovasc Pharmacol. 1995;25(Suppl):S80-S84.
9. Moller DR, Wysocka M, Greenlee BM, et al. Inhibition of human interleukin-12 production by pentoxifylline. Immunology. 1997;91:197-203.
10. Costabel U. The alveolitis of hypersensitivity pneumonitis. Eur Respir J. 1988;1:5-9.
11. Dai H, Guzman J, Satake N, Abdoh Z, Costabel U. Production of soluble TNF receptors and TNFα by alveolar macrophages in sarcoidosis and extrinsic allergic alveolitis [abstract]. Am J Respir Crit Care. 1999;159:A339.
12. Denis M, Cormier Y, Fournier M, Tardif J, Laviolette M. Tumor necrosis factor plays an essential role in determining hypersensitivity pneumonitis in a mouse model. Am J Respir Cell Mol Biol. 1991;5:477-483.
13. Denis M, Bedard M, Laviolette M, Cormier Y. A study of monokine release and natural killer activity in the bronchoalveolar lavage of subjects with Farmer's lung. Am Rev Respir Dis. 1993;147:934-939.
14. Denis M, Cormier Y, Laviolette M. Murine hypersensitivity pneumonitis: a study of cellular infiltrates and cytokine production and its modulation by cyclosporine A. Am J Respir Cell Mol Biol. 1992;6:68-74.
15. Dakhama A, Israel-Assayag E, Cormier Y. Role of interleukin-2 in the development and persistence of lymphocytic alveolitis in farmer's lung. Eur Respir J. 1998;11:1281-1286.
16. Denis M. Proinflammatory cytokines in hypersensitivity pneumonitis. Am J Respir Crit Care Med. 1995;151:164-169.
17. Sugiyama Y, Kasahara T, Mukaida N, Matsushima K, Kitamura S. Chemokines in bronchoalveolar lavage fluid in summer-type hypersensitivity pneumonitis. Eur Respir J. 1995;8:1084-1090.
18. Gudmundsson G, Bosch A, Davidson BL, Berg DJ, Hunninghake GW. Interleukin-10 modulates the severity of hypersensitivity pneumonitis in mice. Am J Respir Cell Mol Biol. 1998; 19:812-818.
19. Gudmundsson G, Monick MM, Hunninghake GW. IL-12 modulates expression of hypersensitivity pneumonitis. J Immunol. 1998;161:991-999.
20. Tong ZH, Dai HP, Chen BM, Guzman J, Abdoh Z, Costabel U. Inhibition of cytokine release from alveolar macrophages in pulmonary sarcoidosis by pentoxifylline: comparison with dexamethasone. Chest. 2003;124:1526-1532.
21. Zheng L, Teschler H, Guzman J, Hubner K, Striz I, Costabel U. Alveolar macrophage TNF-α release and BAL cell phenotypes in sarcoidosis. Am J Respir Crit Care Med. 1995;152: 1061-1066.
22. Tsuji M, Dimov VB, Yoshida T. In vivo expression of monokine and inducible nitric oxide synthase in experimentally induced pulmonary granulomatous inflammation: evidence for sequential production of interleukin-1, inducible nitric oxide synthase, and tumor necrosis factor. Am J Pathol. 1995;147: 1001-1015.
23. Flory CM, Jones ML, Miller BF, Warren JS. Regulation roles of tumor necrosis factor-α and interleukin-1 β in monocyte chemoattractant protein-1-mediated pulmonary granuloma formation in the rat. Am J Pathol. 1995;146:450-462.
24. Chensue SW, Warmington KS, Ruth JH, Lincoln P, Kunkel SL. Cytokine function during mycobacterial and schistosomal antigen-induced pulmonary granuloma formation: local and regional participation of IFN-γ, IL-10, and TNF. J Immunol. 1995;154:5969-5976.
25. Chensue SW, Warmington K, Ruth J, Lincoln P, Kuo MC, Kunkel SL. Cytokine responses during mycobacterial and schistosomal antigen-induced pulmonary granuloma formation: production of Th1 and Th2 cytokines and relative contribution of tumor necrosis factor. Am J Pathol. 1994;145:1105-1113.
26. Kasama T, Kobayashi K, Yamagata N, et al. Augmentation of pulmonary foreign body granulomatous inflammation in mice by lipopolysaccharide: involvement of macrophage activation and tumor necrosis factor-α. Int Arch Allergy Immunol. 1992; 97:130-138.
27. Denis M, Chadirian E. Murine hypersensitivity pneumonitis: bidirectional role of interferon-γ. Clin Exp Allergy. 1992;22: 783-792.
28. Marcinkiewicz J, Grabowska A, Lauterbach R, Bobek M. Differential effects of pentoxifyllion, a non-specific phosphodiesterase inhibitor, on the production of IL-10, IL-12 P40 and P35 subunits by murine peritoneal macrophages. Immunopharmacology. 2000;49:335-343.
29. Zeni F, Pain P, Vindimian M, et al. Effects of pentoxifylline on circulating cytokine concentrations and hemodynamics in patients with septic shock: results from a double-blind, randomized, placebo-controlled study. Crit Care Med. 1996;24:207-214.
30. Rott O, Cash E, Fleischer B. Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T-helper type 1, but not type 2, associated lymphokine production, prevents induction of experimental auto-immune encephalitis in Lewis rats. Eur J Immunol. 1993;23:1745-1751.
31. Samardzic T, Jankovic V, Stosic-Grujicic S, Popadic D, Trajkovic V. Pentoxifylline inhibits the synthesis and IFN-γ-inducing activity of IL-18. Clin Exp Immunol. 2001;124:274-281.
32. 2+ influx by pentoxifylline in NR8383 alveolar macrophages. Immunopharmacology. 1999;43:47-58.
33. Wells JN, Kramer GL. Phosphodiesterase inhibitors as tools in cyclic nucleotide research: a precautionary comment. Mol Cell Endocrinol. 1981;23:1-3.
34. Kambayashi T, Jacob CO, Zhou D, Mazurek N, Fong M, Strassmann G. Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNFα and IL-6 by endotoxin-stimulated macrophages. J Immunol. 1995;155:4909-4916.
35. Lew W, Oppenheim JJ, Matsushima K. Analysis of the suppression of IL-1α and IL-1β production in human peripheral blood mononuclear adherent cells by a glucocorticoid hormone. J Immunol. 1988;140:1895-1902.
36. Wu CY, Fargeas C, Nakajima T, Delespesse G. Glucocorticoids suppress the production of interleukin 4 by human lymphocytes. Eur J Immunol. 1991;21:2645-2647.
37. Williams CM, Coleman JW. Induced expression of mRNA for IL-5, IL-6, TNF, MIP-2 and IFN immunologically activated rat peritoneal mast cells: inhibition by dexamethasone and cyclosporin A. Immunology. 1995;86:244-249.
38. Fushimi T, Okayama H, Seki T, Shimura S, Shirato K. Dexamethasone suppressed gene expression and production of interleukin-10 by human peripheral blood mononuclear cells and monocytes. Int Arch Allergy Immunol. 1997;112:13-18.
39. Tobler A, Meier R, Seitz M, Dewald B, Baggiolini M, Fey MF. Glucocorticoids downregulate gene expression of GM-CSF, NAP/IL-8 and IL-6, but not of M-CSF, in human fibroblasts. Blood. 1992;79:45-51.
40. Waage A, Bakke O. Glucocorticoids suppress the production of tumour necrosis factor by lipopolysaccharide-stimulated human monocytes. Immunology. 1988;63:299-302.
41. Arya SK, Wong-Staal F, Gallo RC. Dexamethasone-mediated inhibition of human T cell growth factor and γ-interferon messenger RNA. J Immunol. 1984;133:273-276.
42. Schmidt-Choudhury A, Furuta GT, Lavigne JA, Galli SJ, Wershil BK. The regulation of tumor necrosis factor-α production in murine mast cells: pentoxifylline or dexamethasone inhibits IgE-dependent production of TNF-α by distinct mechanisms. Cell Immunol. 1996;171:140-146.
43. Zabel P, Entzian P, Dalhoff K, Schlaak M. Pentoxifylline in treatment of sarcoidosis. Am J Respir Crit Care Med. 1997;155: 1665-1669.